<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2217">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04681157</url>
  </required_header>
  <id_info>
    <org_study_id>7754</org_study_id>
    <nct_id>NCT04681157</nct_id>
  </id_info>
  <brief_title>Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19</brief_title>
  <acronym>STras-Cov-2</acronym>
  <official_title>Retrospective Study on Anosmias and Ageusias Linked to Infection by SARS-Cov 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Odor and taste disturbances have increased dramatically during this time of the COVID-19&#xD;
      pandemic. Currently, we have very little information on the demographic and clinical&#xD;
      characteristics of the affected population, on the severity and course of the olfactory /&#xD;
      taste loss.&#xD;
&#xD;
      The main objective of this research is to analyze the epidemiological, demographic and&#xD;
      clinical characteristics of patients suspected or already confirmed of infection with&#xD;
      SARS-Cov2 presenting with anosmia and / or ageusia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 3, 2020</start_date>
  <completion_date type="Anticipated">April 3, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 3, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective analysis of demographic and clinical characteristics of patients with suspected or already confirmed SARS-Cov2 infection with anosmia and / or ageusia</measure>
    <time_frame>The files analysed retrospectily from February 01, 2020 to June 03, 2020 will be examined]</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Covid-19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patient having had a loss of smell and / or taste that occurred during the period of&#xD;
        the Covid-19 epidemic with or without other symptom (s) suggestive of a Covid infection -19&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Major subject (≥18 years old)&#xD;
&#xD;
          -  Subject having had a loss of smell and / or taste that occurred during the period of&#xD;
             the Covid-19 epidemic with or without other symptom (s) suggestive of a Covid&#xD;
             infection -19&#xD;
&#xD;
          -  Subject with suspected or confirmed Covid-19 infection&#xD;
&#xD;
          -  Subject taken care of by the ENT service&#xD;
&#xD;
          -  Subject not having expressed his opposition, after information, to the reuse of his&#xD;
             data for the purposes of this research.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject having expressed opposition to participating in the study&#xD;
&#xD;
          -  Subject under guardianship or guardianship&#xD;
&#xD;
          -  Subject under safeguard of justice&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marion RENAUD, MD</last_name>
    <phone>33 3 88 12 61 89</phone>
    <email>marion.renaud@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <phone>33 3 88 11 66 90</phone>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Strasbourg University Hospitals - Otorhino-Laryngology Department</name>
      <address>
        <city>Strasbourg</city>
        <state>Starsbourg</state>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion RENAUD, MD</last_name>
      <phone>33 3 88 12 61 89</phone>
      <email>marion.renaud@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Saïd CHAYER, PhD, HDR</last_name>
      <phone>33 3 88 11 66 90</phone>
      <email>said.chayer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Marion RENAUD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian DEBRY, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François LEFEBVRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume TRAU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandra LEON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 22, 2020</study_first_submitted>
  <study_first_submitted_qc>December 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>December 23, 2020</last_update_submitted>
  <last_update_submitted_qc>December 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Covid-19</keyword>
  <keyword>Odor disturbance</keyword>
  <keyword>Taste disturbances</keyword>
  <keyword>SARS-Cov2</keyword>
  <keyword>Anosmia</keyword>
  <keyword>Ageusia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olfaction Disorders</mesh_term>
    <mesh_term>Ageusia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

